CTI BIOPHARMA CORP (CTI) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	30.4	65.4	40.4	31.1	36.4	27.2	44.0	128.2
Short-term investments	49.5		12.1	2.5	30.6
Accounts receivable, net	15.4						0.4	0.3
Inventories	0.7						1.5	2.8
Other current assets	3.3	2.9	1.9	1.9	15.5	19.7	9.9	3.7
Total current assets	99.4	68.4	54.3	35.6	82.5	46.9	55.8	135.0
Property, plant, and equipment, net		0.2	0.7	1.2	1.8	2.4	3.0	3.7
Intangibles	23.2
Other fixed assets	3.3	3.9	3.2	9.5	5.5	5.6	5.0	5.5
Total assets	125.9	72.4	58.2	46.3	89.8	54.9	63.8	144.2

Accounts payable	2.0	3.9	1.6		4.5	2.6	7.2	10.6
Accrued expenses	29.4	12.7	7.2	11.6	12.9	13.9	24.8	22.1
Current portion of long-term debt	47.9	47.4	4.5	4.8	4.8	0.4	7.9	37.4
Current portion of long-term debt	47.9	47.4	4.5	4.8	4.8	0.4	7.9	37.4
Deferred revenues							0.1	0.6
Other current liabilities	1.8	2.7	3.8	2.1	0.9	2.3	0.6	1.7
Total current liabilities	81.1	66.7	17.0	18.5	23.1	19.3	40.6	72.4
Long-term debt				4.5	9.3	13.6	11.3	19.1
Other liabilities	62.4	2.0	1.2	5.4	4.6	6.0	4.1	5.3
Total liabilities	143.5	68.7	18.2	28.4	36.9	38.8	56.1	96.8

Shareholders' equity [+]	-17.6	3.8	40.0	17.9	52.9	16.1	7.8	47.4
Paid-in capital	2,501.2	2,429.6	2,368.0	2,299.2	2,294.0	2,223.4
Retained earnings	-2,518.9	-2,425.9	-2,328.0	-2,275.6	-2,224.7	-2,195.3	-2,150.3	-2,098.3
Tangible shareholders' equity	-40.8	3.8	40.0	17.9	52.9	16.1	7.8	47.4